// App-Quantinova.ai

2902 : The Initial Presentation of Cerebrovascular Disease Attributed to Lupus Is Most Frequent Early in the Disease Course: Results from an International, Inception Cohort Study

Researchers

Presenter

  • John G. Hanly

Principal Investigators

  • Qiuju Li

  • Li Su

  • David A. Isenberg

  • Anisur Rahman

  • Ellen M. Ginzler

  • Michelle Petri

  • Ian N. Bruce

  • Murray Urowitz

  • Juanita Romero-Diaz

  • C. Gordon

  • Sang-Cheol Bae

  • Sasha R Bernatsky

  • Ann Clarke

  • Daniel J Wallace

  • Joan T. Merrill

Medical Centers

  • Department of Rheumatology, Univ Hospital Lund, Lund, Sweden

  • Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

  • Medicine/Box , SUNY-Downstate, Brooklyn, NY

  • Nova Scotia Rehab Site, Division of Rheumatology, Capital Health and Dalhousie University, Halifax, NS, Canada

  • Toronto Western Hospital, Toronto, ON, Canada

  • School of Immunity and Infection College of Medical and Dental Sciences University of Birmingham, Edgbaston Birmingham, United Kingdom

  • Medcl Univ of South Carolina, Charleston, SC

  • UAB, Birmingham, AL

  • Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea,

Locations

  • Canada

  • Republic of South Korea

  • Turkey

  • United Kingdom

  • United States

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Transient ischemic attack

  • Venous thrombosis

  • Coronary Artery Disease

  • Stroke

  • Lupus

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim